Message boards rumoring Novartis is looking at taking ARRY out as they dropped their bid for ONXX, want something cheaper, and not already FDA approved.
If you just want to make up pumpisms (is that a word?), at least make them rational. Perhaps partner for asthma (or less likely pain).
A buyout is not all that likely given the nature of the company.
"Pumpisms" validate the Amazing Merrimack.
Trademark your word, 'pumpisms' kind of catchy. What is the nature of ARRY that does not warrant a takeover target?
That would be a big surprise. There are no home runs in ARRY's pipeline.
been trying to tell you guys this but nobody , except a few have listens. I only buy co's with huge buyout potential and have done hundreds of hrs of DD . I KNOW ARRY will be bought this year :)
Will you guarantee this? If they aren't bought out will you buy my shares at $15 apiece?